Disclosures for "Patterns of discontinuation of Epilepsy Specific Anti-Seizure Medications in Medicare Beneficiaries"
-
Dr. Sun has nothing to disclose.
-
Miss Cazé de Medeiros has nothing to disclose.
-
Julianne Brooks has nothing to disclose.
-
Mr. Sankaranarayanan has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for eNova. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Moura has received research support from NIH-NIA - 1K08AG053380-01A1. The institution of Dr. Moura has received research support from NIH-NIA 5R01AG062282-02 . The institution of Dr. Moura has received research support from NIH-NIA 2P01AG032952-11 . The institution of Dr. Moura has received research support from NIH- NIA 3R01AG062282-03S1 . The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America .